Colorado BioScience Association Announces Spring Industry Symposium

Sessions in 2015’s most comprehensive industry event to cover healthcare data, regulatory and reimbursement, due diligence and intellectual property considerations

DENVER--()--Colorado BioScience Association (CBSA) brings to focus the revolutionary role of healthcare data to lower costs, improve quality and provide better outcomes for patients. A keynote luncheon on the Competitive Advantages Fueled by the Health Data Ecosystem kicks off the CBSA Spring Industry Symposium Wednesday, May 13th at the Omni Interlocken Resort in Broomfield.

The year’s most comprehensive bioscience event brings together a broad group of experts to share new perspectives and fresh insights through case studies and success stories. In-depth, tracked sessions on the opportunities and challenges facing the industry will round out the afternoon agenda.

Highlights of the CBSA Spring Industry Symposium include:

  • Data – Gain a competitive advantage with healthcare data with keynote speaker Christopher Boone, Ph.D., Executive Director, Health Data Consortium.
  • Regulatory – Patient-focused development, new approaches at the FDA.
  • Due Diligence – Prepare for due diligence before its necessary and due diligence case studies. Reimbursement – The role of the Affordable Care Act and reimbursement considerations in product development.
  • MedTech – Collaborative arrangements in commercializing devices and diagnostics and key intellectual property considerations for the industry.

April Giles, President & CEO of CBSA, says:

“CBSA is proud to bring together an influential group of thought leaders and innovators from our community to talk about industry trends, share success stories and identify what’s next for the bioscience industry. This information-rich event will address the immediate opportunities and challenges our industry leaders face with detailed, in-depth sessions and interactive case studies.”

In addition to discussion leaders and panelists from Faegre Baker Daniels (Regulatory and Reimbursement), Fox Rothchild LLP (Due Diligence) and Snell & Wilmer (Medtech), experts from Emerson Consultants, Mead Consulting, Surefire Medical, Cerapedics, Endoshape, the University of Colorado Technology Transfer Office, Biodesix, Medtronic and North Highland will share insights and case studies as part of the panel discussions.

The symposium will be held from noon-5 p.m. at the Omni Interlocken Resort, 500 Interlocken Boulevard, in Broomfield with a cocktail networking reception immediately following the event. Registration is $100 for CBSA members and $175 for non-members.

Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn

About the Colorado BioScience Association

The Colorado BioScience Association (CBSA) is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 350 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, advocate for policies that support a strong bioscience industry in the state, and speak with a single voice on behalf of the industry. For more information, visit


Primavera Group for Colorado BioScience Association
Sheliah Reynolds, 720-289-4739

Release Summary

Colorado BioScience Association (CBSA) hosts 2015's most comprehensive bioscience event, with a broad group of experts to share new perspectives and fresh insights through case studies.


Primavera Group for Colorado BioScience Association
Sheliah Reynolds, 720-289-4739